These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39212374)

  • 41. [ESC guidelines on the management of valvular heart disease. What has changed and what is new?].
    Mangner N; Schuler G
    Herz; 2013 Dec; 38(8):828-37. PubMed ID: 24169934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study.
    Huang X; Dhruva SS; Yuan X; Bai X; Lu Y; Yan X; Liu J; Li W; Hu D; Ji R; Gao M; Miao F; Li J; Ge J; Krumholz HM; Li J
    BMJ Open; 2021 Nov; 11(11):e052946. PubMed ID: 34732492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Valvular heart disease in Japan: Characteristics and treatment of patients in acute care hospitals in 2019.
    Izumi C; Matsuyama R; Asaoka M; Iwasaki K; Takeshima T; Murphy S; Teng L; Igarashi A
    J Cardiol; 2023 Jul; 82(1):29-34. PubMed ID: 36963659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Valvular Heart Disease Epidemics.
    Domenech B; Pomar JL; Prat-González S; Vidal B; López-Soto A; Castella M; Sitges M
    J Heart Valve Dis; 2016 Jan; 25(1):1-7. PubMed ID: 29505225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recovery of left ventricular function after surgery for aortic and mitral regurgitation with heart failure.
    Lai WT; Chen IC; Hsiung MC; Lin TC; Huang KC; Chang CY; Wei J
    Int J Cardiol Cardiovasc Risk Prev; 2024 Dec; 23():200329. PubMed ID: 39295958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Echocardiographic assessment of mitral stenosis and its associated valvular lesions in 205 patients and lack of association with mitral valve prolapse.
    Sagie A; Freitas N; Chen MH; Marshall JE; Weyman AE; Levine RA
    J Am Soc Echocardiogr; 1997 Mar; 10(2):141-8. PubMed ID: 9083969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The clinical impact of valvular heart disease in a population-based cohort of subjects aged 80 and older.
    Rezzoug N; Vaes B; de Meester C; Degryse J; Van Pottelbergh G; Mathei C; Adriaensen W; Pasquet A; Vanoverschelde JL
    BMC Cardiovasc Disord; 2016 Jan; 16():7. PubMed ID: 26754575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy).
    Ezekowitz MD; Nagarakanti R; Noack H; Brueckmann M; Litherland C; Jacobs M; Clemens A; Reilly PA; Connolly SJ; Yusuf S; Wallentin L
    Circulation; 2016 Aug; 134(8):589-98. PubMed ID: 27496855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of Acquired Valvular Heart Disease by the Pediatrician: When to Follow, When to Refer for Intervention? Part II.
    Saxena A
    Indian J Pediatr; 2015 Nov; 82(11):1042-9. PubMed ID: 26138578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo model of drug-induced valvular heart disease in rats: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology.
    Droogmans S; Franken PR; Garbar C; Weytjens C; Cosyns B; Lahoutte T; Caveliers V; Pipeleers-Marichal M; Bossuyt A; Schoors D; Van Camp G
    Eur Heart J; 2007 Sep; 28(17):2156-62. PubMed ID: 17636306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A hospital-based survey of patients with severe valvular heart disease in China.
    Hu P; Liu XB; Liang J; Zhu QF; Pu CX; Tang MY; Wang JA
    Int J Cardiol; 2017 Mar; 231():244-247. PubMed ID: 27908608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation.
    Cahill TJ; Prothero A; Wilson J; Kennedy A; Brubert J; Masters M; Newton JD; Dawkins S; Enriquez-Sarano M; Prendergast BD; Myerson SG
    Heart; 2021 May; 107(12):1003-1009. PubMed ID: 33674352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the prevalence of coronary artery disease in patients with valvular heart disease.
    Emren ZY; Emren SV; Kılıçaslan B; Solmaz H; Susam İ; Sayın A; Abud B; Aydın M; Bayturan Ö
    J Cardiothorac Surg; 2014 Sep; 9():153. PubMed ID: 25179559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
    De Caterina R; Renda G; Carnicelli AP; Nordio F; Trevisan M; Mercuri MF; Ruff CT; Antman EM; Braunwald E; Giugliano RP
    J Am Coll Cardiol; 2017 Mar; 69(11):1372-1382. PubMed ID: 28302288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences in Cardiac Remodeling in Left-Sided Valvular Regurgitation: Implications for Optimal Definition of Significant Aortic Regurgitation.
    Vejpongsa P; Xu J; Quinones MA; Shah DJ; Zoghbi WA
    JACC Cardiovasc Imaging; 2022 Oct; 15(10):1730-1741. PubMed ID: 35842362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease.
    Antunes MJ; Rodríguez-Palomares J; Prendergast B; De Bonis M; Rosenhek R; Al-Attar N; Barili F; Casselman F; Folliguet T; Iung B; Lancellotti P; Muneretto C; Obadia JF; Pierard L; Suwalski P; Zamorano P;
    Eur J Cardiothorac Surg; 2017 Dec; 52(6):1022-1030. PubMed ID: 28950325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transcatheter aortic valve implantation reduces grade of concomitant mitral and tricuspid valve regurgitation and pulmonary hypertension.
    Wilbring M; Tugtekin SM; Ritzmann M; Arzt S; Schmidt T; Matschke K; Kappert U; Alexiou K
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):818-24. PubMed ID: 24574441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and Prognostic Implications of Amyloidosis in Valvular Heart Disease.
    Hussain B; Duhan S; Mahmood A; Al-Alawi L; Vargas C; Khan S; Ali Z; Waqar F; Alfonso C; Cuevas C; Alexander T
    Curr Probl Cardiol; 2023 Oct; 48(10):101811. PubMed ID: 37209794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.
    Mehr M; Karam N; Taramasso M; Ouarrak T; Schneider S; Lurz P; von Bardeleben RS; Fam N; Pozzoli A; Lubos E; Boekstegers P; Schillinger W; Plicht B; Eggebrecht H; Baldus S; Senges J; Maisano F; Hausleiter J;
    JACC Cardiovasc Interv; 2020 Mar; 13(5):543-550. PubMed ID: 31954679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased Risk of Valvular Heart Disease in Systemic Sclerosis: An Underrecognized Cardiac Complication.
    Kurmann RD; El-Am EA; Radwan YA; Sandhu AS; Crowson CS; Matteson EL; Warrington KJ; Mankad R; Makol A
    J Rheumatol; 2021 Jul; 48(7):1047-1052. PubMed ID: 33452164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.